Methodological notes by company and year
Methodological Notes by Year / Company
Every company disclosing data on Disclosure UK about healthcare professionals (HCPs), other relevant decision makers (ORDMs), and healthcare organisations (HCOs) has provided a Methodological Note which explains how they compiled their data. Please ensure that you consider these notes when you are exploring the data.
To download a full HCP, ORDM and HCO dataset for each year, please visit the Disclosure UK search.
|
A. MENARINI |
2025 2024 2023 |
ABBVIE |
2025 2024 2023 |
||
|
ACCORD |
2025 2024 2023 |
ADVANZ UK & IRE |
2025 2024 2023 |
||
|
AGB |
2025 2024 2023 |
AGUETTANT |
2025 2024 2023 |
||
|
ALEXION |
2025 2024 2023 |
ALFASIGMA |
2025 2024 - |
||
|
ALIMERA SCIENCES |
2025 2024 2023 |
ALK-ABELLO |
2025 2024 2023 |
||
|
ALLIANCE |
2025 2024 2023 |
ALMIRALL |
2025 2024 2023 |
||
|
ALNYLAM |
2025 2024 2023 |
ALTURIX |
2025 2024 2023 |
||
|
AMGEN |
2025 2024 2023 |
AMICUS THERAPUTICS |
2025 2024 2023 |
||
|
AMRYT |
- 2023 - |
ANGELINI |
2025 2024 2023 |
||
|
ASCENDIS |
2025 2024 - |
ASPEN |
- 2024 - |
||
|
ASTELLAS |
2025 2024 2023 |
ASTRAZENECA |
2025 2024 2023 |
||
|
ATNAHS |
2025 2024 2023 |
B. BRAUN MEDICAL |
2025 - - |
||
|
BAUSCH & LOMB |
2025 2024 2023 |
BAXTER HEALTHCARE |
2025 2024 2023 |
||
|
BAYER |
2025 2024 2023 |
BESINS HEALTHCARE |
2025 2024 2023 |
||
|
BIAL |
2025 2024 2023 |
BIO PRODUCTS LABORATORY |
2025 2024 2023 |
||
|
BIOCRYST |
2025 2024 2023 |
BIOGEN IDEC |
2025 2024 2023 |
||
|
BIOMARIN EUROPE |
2025 2024 2023 |
BIOPROJET |
2025 2024 2023 |
||
|
BLUE EARTH DIAGNOSTICS |
2025 - - |
BLUE EARTH GROUP |
- 2024 2023 |
||
|
BOEHRINGER INGELHEIM |
2025 2024 2023 |
BRACCO |
2025 2024 2023 |
||
|
BRISTOL-MYERS SQUIBB |
2025 2024 2023 |
BRITANNIA |
2025 2024 2023 |
||
|
CAMURUS |
2025 2024 2023 |
CELLTRION HEALTHCARE |
2025 2024 2023 |
||
|
CHIESI |
2025 2024 2023 |
CHUGAI |
2025 2024 2023 |
||
|
CIPLA |
2025 2024 2023 |
CLINUVEL |
2025 2024 2023 |
||
|
CNX THERAPEUTICS |
2025 2024 - |
CONSILIENT HEALTH |
2025 2024 2023 |
||
|
CROMA |
2025 2024 2023 |
CSL BEHRING |
2025 2024 2023 |
||
|
DAIICHI SANKYO |
2025 2024 2023 |
DERMAL LABORATORIES |
2025 2024 2023 |
||
|
DIURNAL |
- 2024 2023 |
DR FALK |
2025 2024 2023 |
||
|
ECLOSIX |
2025 - - |
EISAI |
2025 2024 2023 |
||
|
ELI LILLY |
2025 2024 2023 |
ESTEVE |
2025 2024 - |
||
|
ETHYPHARM GROUP |
2025 2024 2023 |
EVER |
2025 2024 2023 |
||
|
EXELTIS |
2025 2024 2023 |
FERRING |
2025 2024 2023 |
||
|
FLYNN |
2025 2024 2023 |
FRESENIUS KABI |
2025 2024 2023 |
||
|
FRESENIUS MEDICAL CARE |
2025 2024 2023 |
GALEN |
2025 2024 2023 |
||
|
GE HEALTHCARE |
2025 2024 2023 |
GEDEON RICHTER |
2025 2024 2023 |
||
|
GILEAD |
2025 2024 2023 |
GLAXOSMITHKLINE |
2025 2024 2023 |
||
|
GRUNENTHAL |
2025 2024 2023 |
GUERBET |
2025 2024 2023 |
||
|
HRA |
- 2024 2023 |
IBSA |
2025 2024 2023 |
||
|
IDORSIA |
2025 2024 2023 |
IMMEDICA |
2025 2024 2023 |
||
|
INCYTE |
2025 2024 - |
INDIVIOR |
2025 2024 2023 |
||
|
IPSEN |
2025 2024 2023 |
IQVIA IES |
2025 2024 2023 |
||
|
JANSSEN-CILAG |
- 2023 - |
JANSSEN-CILAG (J&J CO) |
2025 2024 - |
||
|
JAZZ |
2025 2024 2023 |
KALVISTA |
2025 - - |
||
|
KORA |
2025 2024 2023 |
L.D. COLLINS |
2025 2024 2023 |
||
|
LEADIANT BIOSCIENCES |
2025 2024 2023 |
LEO |
2025 2024 2023 |
||
|
LUNDBECK |
2025 2024 2023 |
LUPIN |
2025 2024 2023 |
||
|
LUYE |
2025 2024 - |
MEDICE |
2025 2024 2023 |
||
|
MENARINI STEMLINE |
2025 2024 2023 |
MERCK SERONO |
2025 2024 2023 |
||
|
MERCK SHARP & DOHME |
2025 2024 2023 |
MERZ |
2025 2024 2023 |
||
|
MITSUBISHI TANABE |
2025 2024 2023 |
MODERNA |
2025 2024 2023 |
||
|
MUNDIPHARMA MEDICAL |
2025 2024 2023 |
MUNDIPHARMA RESEARCH |
2025 2024 2023 |
||
|
NAPP |
2025 2024 2023 |
NEON HEALTHCARE |
2025 2024 2023 |
||
|
NEURAXPHARM |
2025 2024 2023 |
NEUROCRINE |
2025 - - |
||
|
NORGINE |
2025 2024 2023 |
NOVARTIS |
2025 2024 2023 |
||
|
NOVO NORDISK |
2025 2024 2023 |
OCTAPHARMA |
2025 2024 2023 |
||
|
ORGANON |
2025 2024 2023 |
ORION |
2025 2024 2023 |
||
|
ORPHALAN |
2025 2024 2023 |
OTSUKA |
2025 2024 2023 |
||
|
OUTLOOK |
2025 2024 - |
PACIRA BIOSCIENCES |
2025 2024 2023 |
||
|
PAION |
2025 2024 2023 |
PARI MEDICAL |
2025 2024 2023 |
||
|
PFIZER |
2025 2024 2023 |
PHARMA NORD |
- 2024 2023 |
||
|
PHARMAMAR |
2025 - 2023 |
PIERRE FABRE |
2025 2024 2023 |
||
|
PIRAMAL CRITICAL CARE |
- 2024 - |
PROVECA |
2025 2024 2023 |
||
|
PROVEPHARM |
2025 2024 - |
PTC THERAPEUTICS |
2025 2024 2023 |
||
|
RECKITT |
2025 2024 2023 |
RECORDATI |
2025 2024 2023 |
||
|
RECORDATI RARE DISEASES |
2025 2024 2023 |
RECORDATI UK |
2025 2024 - |
||
|
REGENERON |
2025 2024 2023 |
RHYTHM |
2025 2024 2023 |
||
|
ROCHE |
2025 2024 2023 |
ROSEMONT |
2025 2024 2023 |
||
|
SAMSUNG BIOEPIS |
2025 2024 2023 |
SANOFI AVENTIS |
2025 2024 2023 |
||
|
SANTEN |
2025 2024 2023 |
SANTHERA |
2025 2024 - |
||
|
SEQIRUS |
2025 2024 2023 |
SERVIER |
2025 2024 2023 |
||
|
SHIONOGI BV |
2025 2024 2023 |
SIFI |
2025 2024 2023 |
||
|
SOBI |
2025 2024 2023 |
STD PRODUCTS |
2025 - 2023 |
||
|
STIRLING ANGLIAN |
2025 2024 2023 |
SUN |
2025 2024 2023 |
||
|
SYNER-MED |
2025 2024 2023 |
SYRI |
- 2023 - |
||
|
TAKEDA |
2025 2024 2023 |
TEVA |
2025 2024 2023 |
||
|
THEA |
2025 2024 2023 |
THORNTON & ROSS |
2025 - - |
||
|
TILLOTTS |
2025 2024 2023 |
UCB |
2025 2024 2023 |
||
|
UNITED THERAPEUTICS |
2025 - - |
VALNEVA |
2025 2024 2023 |
||
|
VANTIVE |
2025 - - |
VERITON |
2025 2024 2023 |
||
|
VIFOR GROUP |
2025 2024 2023 |
VISUFARMA |
2025 2024 2023 |
||
|
ZAMBON |
2025 2024 2023 |
Last reviewed date: 01 July 2026
Next review date: 01 July 2029